# PACIFICA (NCT03165734)

> A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

No report yet. It can be ordered.

- Drugs tested: pacritinib
- Indication: myelofibrosis with severe thrombocytopenia

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03165734
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Swedish Orphan Biovitrum
- Conditions: Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
- Interventions: Pacritinib; Physician's Choice medications
- Enrollment: 407
- Primary outcome: Spleen volume
- Primary outcome: Total Symptom Score (TSS) (excluding tiredness)

## Indexed commentary on PACIFICA so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- Podcasts: 19
- X threads: 15
- YouTube: 14

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=pacifica-nct03165734

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03165734", "email": "<work email>"}; the inbox owner confirms by the emailed link.